Dhanvantri Jeevan Rekha Limited

BSE:531043 Stock Report

Market Cap: ₹89.3m

Dhanvantri Jeevan Rekha Past Earnings Performance

Past criteria checks 3/6

Dhanvantri Jeevan Rekha has been growing earnings at an average annual rate of 51.5%, while the Healthcare industry saw earnings growing at 23.2% annually. Revenues have been growing at an average rate of 8% per year. Dhanvantri Jeevan Rekha's return on equity is 6.1%, and it has net margins of 2.7%.

Key information

51.5%

Earnings growth rate

51.2%

EPS growth rate

Healthcare Industry Growth29.4%
Revenue growth rate8.0%
Return on equity6.1%
Net Margin2.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Dhanvantri Jeevan Rekha makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BSE:531043 Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242176650
30 Jun 24212300
31 Mar 242052650
31 Dec 232002570
30 Sep 23195-1570
30 Jun 23186-1570
31 Mar 23177-2570
31 Dec 22172-2280
30 Sep 22172-2560
30 Jun 221712560
31 Mar 221685570
31 Dec 211696690
30 Sep 21146400
30 Jun 21125-400
31 Mar 21100-14410
31 Dec 20100-1700
30 Sep 20123-1500
30 Jun 20148-1300
31 Mar 20182-300
31 Dec 19179-500
30 Sep 19179-600
30 Jun 19181-100
31 Mar 19168000
31 Dec 18168500
30 Sep 18158900
30 Jun 18144900
31 Mar 18138700
31 Dec 17130100
30 Sep 17127100
30 Jun 17120300
31 Mar 17112500
31 Dec 16105900
30 Sep 16951000
30 Jun 16951000
31 Mar 16931000
31 Dec 158613330
30 Sep 158312330
30 Jun 15801100
31 Mar 15801100
31 Dec 14766280
30 Sep 14755280
30 Jun 1476600
31 Mar 14736280
31 Dec 13729210

Quality Earnings: 531043 has high quality earnings.

Growing Profit Margin: 531043 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 531043 has become profitable over the past 5 years, growing earnings by 51.5% per year.

Accelerating Growth: 531043 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 531043 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (29.6%).


Return on Equity

High ROE: 531043's Return on Equity (6.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies